The molecular characterization of endometrial carcinoma (EC) has recently been included in the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice and the relevance of pathologic parameters in predicting prognosis in each EC molecular subgroup. ECs were classified using immunohistochemistry and next-generation sequencing into the four molecular classes: POLE mutant (POLE), mismatch repair deficient (MMRd), p53 mutant (p53abn), and no specific molecular profile (NSMP). According to the WHO algorithm, 219 ECs were subdivided into the following molecular subgroups: 7.8% POLE, 31% MMRd, 21% p53abn, 40.2% NSMP. Molecular classes as well as ESGO/ESTRO/ESP 2020 risk groups were statistically correlated with disease-free survival. Considering the impact of histopathologic features in each molecular class, stage was found to be the strongest prognostic factor in MMRd ECs, whereas in the p53abn subgroup, only lymph node status was associated with recurrent disease. Interestingly, in the NSMP tumor, several histopathologic features were correlated with recurrence: histotype, grade, stage, tumor necrosis, and substantial lymphovascular space invasion. Considering early-stage NSMP ECs, substantial lymphovascular space invasion was the only independent prognostic factor. Our study supports the prognostic importance of EC molecular classification and demonstrated the essential role of histopathologic assessment in patients' management.
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma / Ruscelli, Martina; Maloberti, Thais; Corradini, Angelo Gianluca; Rosini, Francesca; Querzoli, Giulia; Grillini, Marco; Altimari, Annalisa; Gruppioni, Elisa; Sanza, Viviana; Costantino, Alessia; Ciudino, Riccardo; Errani, Matteo; Papapietro, Alessia; Coluccelli, Sara; Turchetti, Daniela; Ferioli, Martina; Giunchi, Susanna; Dondi, Giulia; Tesei, Marco; Ravegnini, Gloria; Abbati, Francesca; Rubino, Daniela; Zamagni, Claudio; D'Angelo, Emanuela; De Iaco, Pierandrea; Santini, Donatella; Ceccarelli, Claudio; Perrone, Anna Myriam; Tallini, Giovanni; de Biase, Dario; De Leo, Antonio. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - ELETTRONICO. - 13:5(2023), pp. 723.1-723.11. [10.3390/jpm13050723]
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma
Ruscelli, Martina;Maloberti, Thais;Corradini, Angelo Gianluca;Rosini, Francesca;Grillini, Marco;Costantino, Alessia;Ciudino, Riccardo;Errani, Matteo;Papapietro, Alessia;Coluccelli, Sara;Turchetti, Daniela;Ferioli, Martina;Ravegnini, Gloria;Abbati, Francesca;Rubino, Daniela;Zamagni, Claudio;D'Angelo, Emanuela;De Iaco, Pierandrea;Ceccarelli, Claudio;Perrone, Anna Myriam;Tallini, Giovanni;de Biase, Dario;De Leo, Antonio
2023
Abstract
The molecular characterization of endometrial carcinoma (EC) has recently been included in the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice and the relevance of pathologic parameters in predicting prognosis in each EC molecular subgroup. ECs were classified using immunohistochemistry and next-generation sequencing into the four molecular classes: POLE mutant (POLE), mismatch repair deficient (MMRd), p53 mutant (p53abn), and no specific molecular profile (NSMP). According to the WHO algorithm, 219 ECs were subdivided into the following molecular subgroups: 7.8% POLE, 31% MMRd, 21% p53abn, 40.2% NSMP. Molecular classes as well as ESGO/ESTRO/ESP 2020 risk groups were statistically correlated with disease-free survival. Considering the impact of histopathologic features in each molecular class, stage was found to be the strongest prognostic factor in MMRd ECs, whereas in the p53abn subgroup, only lymph node status was associated with recurrent disease. Interestingly, in the NSMP tumor, several histopathologic features were correlated with recurrence: histotype, grade, stage, tumor necrosis, and substantial lymphovascular space invasion. Considering early-stage NSMP ECs, substantial lymphovascular space invasion was the only independent prognostic factor. Our study supports the prognostic importance of EC molecular classification and demonstrated the essential role of histopathologic assessment in patients' management.File | Dimensione | Formato | |
---|---|---|---|
jpm-13-00723-v3 (1).pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
4.56 MB
Formato
Adobe PDF
|
4.56 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.